(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLARIPHARM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CLARIPHARM

ST13

US500000079288484

Class

3, 10

Filing

79288484

Registration

6436343

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

08/03/2026

Trademark type

Combined

Nice classes

3, 10

Filing date

05/12/2020

Registration date

08/03/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/03/2021

Last transaction

08/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

34

Owner location

FR

Examiner

KHOURI, SANI PHILIPPE

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CLARIPHARM

Representatives

Andrew W. Chu CRAFT CHU PLLC

Technical classification

Nice Classes

Class 3Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Non-medicated toilet products intended for female intimate comfortgels and creams

Class 10

Vaginal pessaries; urological apparatus and instruments; gynecological apparatus and instruments; non-chemical contraceptives; uterine syringes; vaginal syringes; urethral syringes; syringes for medical use; probes for medical use; urethral probes; gynecological apparatus; obstetric apparatus; bed pans or pans for medical use; cushions for medical use; artificial implants; gynecological instruments; surgical mirrors; menstrual cups; electronic medical appliances for wound-healing; surgical apparatus and instruments; prostheses for pelvis; silicone protection braces intended for the relief of female intimate pain subsequent to surgery in the lower part of the human body; surgical implants based on artificial materials

Publications

History of USPTO decisions and trademark events.

29 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

08/03/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/29/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/06/2022

FIMP

FINAL DISPOSITION PROCESSED

01/06/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/03/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

08/03/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/18/2021

PUBO

PUBLISHED FOR OPPOSITION

05/18/2021

GPNX

NOTIFICATION PROCESSED BY IB

05/16/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/28/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/28/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/28/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/14/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/25/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/25/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/25/2021

RFNT

REFUSAL PROCESSED BY IB

10/25/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/08/2020

RFRR

REFUSAL PROCESSED BY MPU

10/07/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/17/2020

CNRT

NON-FINAL ACTION WRITTEN

09/16/2020

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

09/10/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/13/2020

CNRT

NON-FINAL ACTION WRITTEN

08/12/2020

DOCK

ASSIGNED TO EXAMINER

08/07/2020

MAFR

APPLICATION FILING RECEIPT MAILED

07/14/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/10/2020

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

07/10/2020

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

06/25/2020

Continuous trademark protection

Get notified about every new filing that threatens CLARIPHARM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.